15 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

MyoCycle Home, MyoCycle Pro

FDA 510(k)
FDA Class 2 ·Neurology

EarQ

FDA UDI
Oticon A/S·05707131318596·G50, MRITE 312 2.4G NFM PB C044 EARQ

Millennium

FDA UDI
Avalign Technologies, Inc.·00190776163860·VAN BUREN URETH SNDS FR

Medline/MMS Sales

FDA UDI
MEDLINE INDUSTRIES, INC.·20080196984340·CIRCUIT-ADULT ANESTHESIA

SCHWERT

FDA UDI
A. Schweickhardt GmbH & Co. KG·E8961701320·Osteotome concav...

Medline Industries, Inc.

FDA UDI
MEDLINE INDUSTRIES, INC.·10080196984343·CIRCUIT-ADULT ANESTHESIA

IN-OVATION® C

FDA UDI
DENTSPLY SIRONA ORTHODONTICS INC.·D807K100132611·IN-OVATION® C Roncone 022 U3-3 CS HK

IN-OVATION® C

FDA UDI
DENTSPLY SIRONA ORTHODONTICS INC.·D807K100132101·IN-OVATION® C Base Rx 022 U3-3 CS HK

MUSE CARDIOLOGY INFORMATION SYSTEM

FDA 510(k)
FDA Class 2 ·Cardiovascular

TRIPORE, MODELS HA, BP90, BP15

FDA 510(k)
FDA Class 2 ·Orthopedic

UNKNOWN KNEE

FDA Adverse Event
Other ·ENCORE MEDICAL, L.P.·Product code JWH·June 22, 2011

OMNIPOD INSULIN PUMP

FDA Adverse Event
Injury ·INSULET CORP·Product code LZG·June 6, 2013

CLINITEK STATUS+

FDA Adverse Event
Malfunction ·SIEMENS HEALTHCARE DIAGNOSTICS·Product code JIL·October 14, 2014

Allura CV20, system code 722031

FDA Enforcement
Class II ·Terminated·Philips North America, LLC·March 25, 2020

Merlin PCS Programmer software model 3330, used with Confirm Rx Insertable Cardiac Monitor (ICM), Model DM3500, Sterile. The firm name on the label of the ICM is St. Jude Medical Cardiac Rhythm Management Division, Sylmar, CA. - Product Usage: The Confirm Rx insertable cardiac monitor is designed to detect arrhythmias and wirelessly transmit data to the Merlin.net Patient Care Network. The Confirm Rx ICM is indicated for the monitoring and diagnostic evaluation of patients who experience unexplained symptoms such as: dizziness, palpitations, chest pain, syncope, and shortness of breath, as well as patients who are at risk for cardiac arrhythmias. It is also indicated for patients who have been previously diagnosed with atrial fibrillation or who are susceptible to developing atrial fibrillation.

FDA Enforcement
Class II ·Terminated·St Jude Medical, Cardiac Rhythm Management Division·January 22, 2020